In our study, GBM samples in the Cancer Genome Atlas (TCGA) database were enrolled in the training set, and cases in the Chinese Glioma Genome Atlas (CGGA) were used for the external validation set, to assess the RCN1-related prognostic signature in GBM. Here, RCN1 is linked to glioblastoma.